127 related articles for article (PubMed ID: 26107197)
21. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.
Velasco A; Bussaglia E; Pallares J; Dolcet X; Llobet D; Encinas M; Llecha N; Palacios J; Prat J; Matias-Guiu X
Hum Pathol; 2006 Nov; 37(11):1465-72. PubMed ID: 16949921
[TBL] [Abstract][Full Text] [Related]
22. PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women.
Gbelcová H; Bakeš P; Priščáková P; Šišovský V; Hojsíková I; Straka Ľ; Konečný M; Markus J; D'Acunto CW; Ruml T; Böhmer D; Danihel Ľ; Repiská V
Anal Cell Pathol (Amst); 2015; 2015():746856. PubMed ID: 26114084
[TBL] [Abstract][Full Text] [Related]
23. PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women.
Gbelcová H; Gergely L; Šišovský V; Straka Ľ; Böhmer D; Pastoráková A; Sušienková K; Repiská V; Korbeľ M; Danihel Ľ; Priščáková P
Physiol Res; 2022 Dec; 71(Suppl 1):S125-S135. PubMed ID: 36592448
[TBL] [Abstract][Full Text] [Related]
24. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH
Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275
[TBL] [Abstract][Full Text] [Related]
25. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
[TBL] [Abstract][Full Text] [Related]
26. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
Garcia-Dios DA; Lambrechts D; Coenegrachts L; Vandenput I; Capoen A; Webb PM; Ferguson K; ; Akslen LA; Claes B; Vergote I; Moerman P; Van Robays J; Marcickiewicz J; Salvesen HB; Spurdle AB; Amant F
Gynecol Oncol; 2013 Feb; 128(2):327-34. PubMed ID: 23219661
[TBL] [Abstract][Full Text] [Related]
27. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
28. PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors.
Yang HP; Meeker A; Guido R; Gunter MJ; Huang GS; Luhn P; d'Ambrosio L; Wentzensen N; Sherman ME
Cancer Causes Control; 2015 Dec; 26(12):1729-36. PubMed ID: 26376893
[TBL] [Abstract][Full Text] [Related]
29. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
30. Pathology of Endometrial Carcinoma.
Lax SF
Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
[TBL] [Abstract][Full Text] [Related]
31. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
Risinger JI; Hayes K; Maxwell GL; Carney ME; Dodge RK; Barrett JC; Berchuck A
Clin Cancer Res; 1998 Dec; 4(12):3005-10. PubMed ID: 9865913
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
33. Expressions and significances of TTF-1 and PTEN in early endometrial cancer.
Zhang HM; Fan TT; Li W; Li XX
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(3 Suppl):20-26. PubMed ID: 28745797
[TBL] [Abstract][Full Text] [Related]
34. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.
Hayes MP; Wang H; Espinal-Witter R; Douglas W; Solomon GJ; Baker SJ; Ellenson LH
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5932-5. PubMed ID: 17062663
[TBL] [Abstract][Full Text] [Related]
35. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
[TBL] [Abstract][Full Text] [Related]
36. Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma.
Hoang LN; McConechy MK; Köbel M; Anglesio M; Senz J; Maassen M; Kommoss S; Meng B; Postovit L; Kelemen LE; Staebler A; Brucker S; Krämer B; McAlpine JN; Gilks CB; Huntsman DG; Lee CH
Int J Gynecol Cancer; 2015 Sep; 25(7):1187-93. PubMed ID: 26166557
[TBL] [Abstract][Full Text] [Related]
37. Molecular alterations in endometrial archived liquid-based cytology.
Di Lorito A; Rosini S; Falò E; Gustapane S; Gomes M; Costa JL; Schmitt FC
Diagn Cytopathol; 2013 Jun; 41(6):492-6. PubMed ID: 22807394
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies.
Wang L; Piskorz A; Bosse T; Jimenez-Linan M; Rous B; Gilks CB; Brenton JD; Singh N; Köbel M
Int J Gynecol Pathol; 2022 Jan; 41(1):12-19. PubMed ID: 33720084
[TBL] [Abstract][Full Text] [Related]
39. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
[TBL] [Abstract][Full Text] [Related]
40. Expression of phosphatase and tensin homologue in imprint smears of endometrial carcinoma.
Kosmas K; Mitropoulou G; Provatas I; Stamoulas M; Marouga A
Cytopathology; 2018 Dec; 29(6):558-564. PubMed ID: 30007089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
